Photocleavable peptide-oligonucleotide conjugates for protein kinase assays by MALDI-TOF MS

Guangchang Zhou1, Faraz Khan, Qing Dai

  • 1Department of Molecular Genetics and Cell Biology, Gordon Center for Integrative Sciences, W522A, The University of Chicago, Chicago, IL 60637, USA.

Molecular Biosystems
|July 10, 2012
PubMed

Insights

This study introduces a novel assay for quantifying protein kinase activity using oligonucleotide-tagged peptides captured by magnetic microparticles. This method enables sensitive, multiplexed analysis crucial for drug discovery and cancer diagnostics.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Analytical Chemistry

Background:

  • Robust methods for analyzing protein tyrosine kinase activity are essential for understanding cancer signaling and developing targeted therapies.
  • Current methods face challenges in high-throughput, quantitative analysis, particularly in complex biological samples.

Purpose of the Study:

  • To develop a novel, highly parallel, and quantitative protein kinase assay.
  • To enable label-free, multiplexed analysis of peptide phosphorylation using mass spectrometry.

Main Methods:

  • Conjugation of oligonucleotide tags to peptide substrates for capture on magnetic microparticles via hybridization.
  • Development of a novel bifunctional cross-linker for reversible peptide-oligonucleotide conjugation.
  • Utilizing MALDI-TOF mass spectrometry for sensitive and specific quantification of peptide phosphorylation after photorelease.

Main Results:

  • Demonstrated efficient capture and sensitive detection of phosphorylated peptides from kinase reactions.
  • Successfully validated the assay by analyzing differential phosphorylation of multiple substrates and measuring inhibitor IC50 values.
  • Achieved high sensitivity and specificity in quantifying relative peptide phosphorylation.

Conclusions:

  • The developed hybridization-mediated multiplexed kinase assay offers a powerful tool for analyzing protein kinase activities.
  • This assay is amenable to screening inhibitors against multiple kinases in parallel, supporting drug discovery and predictive diagnostics.
  • The method provides a robust platform for deciphering oncogenic signaling and advancing personalized medicine.